by emli1120 | Feb 26, 2024 | 2020, Recent Advances in Treatment 2020
From left: Nephrology fellows Dimitri Augustin, MD, MS, and Daniel Watford, MD, MPH, look over data from a patient with kidney disease. The Down-to-Earth Goals of Two Nephrology Fellows From left: Nephrology fellows Dimitri Augustin, MD, MS, and Daniel Watford, MD,...
by emli1120 | Feb 26, 2024 | 2020, Recent Advances in Treatment 2020
Sarcoidosis is a rare disease that can manifest in various ways. Immunology and Rheumatology Faculty Reach Across Divisions to Fight Disease Sarcoidosis is a rare disease that can manifest in various ways. Immunology and Rheumatology Faculty Reach Across Divisions to...
by emli1120 | Feb 26, 2024 | 2020, Recent Advances in Treatment 2020
Sun Kim, MD, MS, a principal investigator for CREDENCE, examines a patient with Type 2 diabetes. CREDENCE Brings Together Multiple Groups in Successful Trial Sun Kim, MD, MS, a principal investigator for CREDENCE, examines a patient with Type 2 diabetes. CREDENCE...
by emli1120 | Feb 26, 2024 | 2020, Recent Advances in Treatment 2020
Jodi Prochaska, PhD, MPH New Approaches to Tobacco Control Jodi Prochaska, PhD, MPH New Approaches to Tobacco Control The tobacco products of today are not just your grandfather’s unfiltered Lucky Strikes or Camels, but rather natural and organic cigarettes,...
by emli1120 | Feb 26, 2024 | 2020, Recent Advances in Treatment 2020
Everett Meyer, MD, PhD, leads a team that replaces immunosuppressive agents with T regulatory cells for patients with specific cancers. Regulatory T Cells Join the Mainstream Everett Meyer, MD, PhD, leads a team that replaces immunosuppressive agents with T regulatory...
